Neurosciences News

Systemic therapy may prolong progression-free survival from primary intraocular lymphoma, according to a retrospective study.

Vitamin A deficiency should be suspected in patients with unexplained decreases in vision and a history of intestinal surgery, according to a study.

Treatment with pyrimethamine and sulfadiazine for the first year of a child’s life can lead to a lasting reduction in brain and ocular damage from congenital toxoplasmosis, according to a study.

SINGAPORE — Contrast sensitivity and uncorrected visual acuity in low myopes, emmetropic presbyopes and post-refractive surgery patients may be improved through a neural adaptation program, preliminary study results show.

MEMPHIS, Tenn. — Three genes that express at different times during retinal development in mice may be the key to developing a treatment for retinoblastoma, researchers at St. Jude Children’s Research Hospital said in a press release.

LISBON, Portugal — Recalling the basic risk factors for uveal melanoma one learned as a resident may help save lives, according to one surgeon.

In a comparison of brachytherapy and enucleation as treatment for ocular melanoma, one study found that patients being treated with brachytherapy had better results for driving and peripheral vision while patients treated through enucleation had less anxiety.

Protein misfolding, which underlies the pathogenesis of some amyloid diseases such as Parkinson’s or Alzheimer’s, may be associated with age-related macular degeneration, according to a study.

WASHINGTON — Patients with persistent or recurrent cutaneous T-cell lymphoma who have been prescribed denileukin diftitox may experience loss of visual acuity with a loss of color vision, according to the manufacturer.

PHILADELPHIA — More than half of the patients who present with uveal metastasis from lung cancer had no known history of the disease and the majority died within a year of presentation, said one ophthalmologist speaking here.